赛尔巴制药将以4.12亿美元收购Y-mAbs治疗公司SERB Pharmaceuticals to Acquire Y-mAbs Therapeutics in $412 Million

动脉网
Aug 06

SERB Pharmaceuticals has announced the acquisition of Y-mAbs Therapeutics.赛尔布制药公司宣布收购Y-mAbs治疗公司。The agreement values Y-mAbs at approximately $412 million in an all-cash transaction.该协议在全现金交易中对Y-mAbs的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10